- Dermatologie > Basaalcelcarcinoom
Naar startpagina oncoline


1 - Avril MF (1997)
Avril MF, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E, et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997; 76: 100-6.
2 - Basset-Seguin N (2001)
Basset-Seguin N, Ibbotson S, Emtestam L. Photodynamic therapy using Metvix® is as efficacious as cryotherapy in BCC, with better cosmetic results. J Eur Acad Dermatol Venereol 2001; 15 Suppl. 2: 226.
3 - Bath FJ (2004)
Bath FJ, Bong J, Perkins W, Williams HC. Interventions for basal cell carcinoma of the skin (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.
4 - Berlin J (2002)
Berlin J, Katz KH, Helm KF, Maloney ME. The significance of tumor persistence after incomplete excision of basal cell carcinoma. J Acad Dermatol 2002; 46: 639.
5 - Bessems P (1989)
Bessems P. The cryosurgical open-cone-spray method [proefschrift]. Maastricht; 1989.
6 - Beutner KR (1999)
Beutner KR, Geisse JK, Helman D, Fox TI, Ginkel A, Owens ML. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 1999; 41: 1002-7.
7 - Bieley HC (1992)
Bieley HC, Kirsner RS, Reyes BA, Garland LD. The use of Mohs micrographic surgery for determination of residual tumour in incompletely excised basal cell carcinoma. J Am Acad Dermatol 1992; 26: 754-6.
8 - Bowers B (2004)
Bowers B, Basset-Seguin N, Colver G, Finlay AY, Neumann HAM, Ulrich C, et al. Guideline for the management of basal cell carcinoma. Guideline subcommittee of the European Dermatology Forum, 2004/2005.
9 - Breuninger H (1991)
Breuninger H, Dietz K. Prediction of subclinical tumor infiltration in basal cell carcinoma. J Surg Oncol 1991; 17: 574-8.
10 - Caccialanza M (2001)
Caccialanza M, Piccinno R, Grammatica A. Radiotherapy of recurrent basal and squamous cell skin carcinomas: a study of 249 re-treated carcinomas in 229 patients. Eur J Dermatol 2001; 11: 25-8.
11 - DeSilva SP (1985)
DeSilva SP, Dellon AL. Recurrence rate of positive margin basal cell carcinoma results of a five-year prospective study. J Surg Oncol 1985; 28: 72-4.
12 - Eide MJ (2005)
Eide MJ, Weinstock MA, Dufresne RG Jr, Neelagaru S, Risica P, Burkholder GJ, et al. Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous cell carcinoma of the skin). J Invest Dermatol 2005; 124: 308-14.
13 - Euvrard S (2003)
Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681-91.
14 - Geisse J (2004)
Geisse J, Caro I, Lindholm J, Golitz L, Stampone P, Owens M. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehiclecontrolled studies. J Am Acad Dermatol 2004; 50: 722-33.
15 - Geisse JK (2002)
Geisse JK, Rich P, Pandya A, Gross K, Andras K, Ginkel A, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol 2002; 47: 390-8.
16 - Gollnick H (2005)
Gollnick H, Barona CG, Frank RG, Ruzicka T, Megahed M, Tebbs V, et al. Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe. Eur J Dermatol 2005; 15: 374-81.
17 - Gooding CA (1965)
Gooding CA, White G, Yatsuhashi M. Significance of marginal extension in excised basal cell carcinoma. N Engl J Med 1965; 273: 923-4.
18 - Graham G (1990)
Graham G, Clark L. Statistical analysis in cryosurgery of skin cancer. Clinics Dermatol 1990; 8: 101-7.
19 - Guix B (2000)
Guix B, Finestres F, Tello J, Palma C, Martinez A, Guix J, et al. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds. Int J Radiat Oncol Biol Phys 2000; 47: 95-102.
20 - Hall VL (1986)
Hall VL, Leppard BJ, McGill J, Kesseler ME, White JE, Goodwin P. Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol 1986; 37: 33-4.
21 - Hauben DJ (1982)
Hauben DJ, Zirkin H, Mahler D, Sacks M. The biologic behaviour of basal cell carcinoma: Part I. Plast Reconstr Surg 1982; 69: 103-9.
22 - Iersel CA van (2005)
Iersel CA van, Velden HVN van de, Kusters CDJ, Spauwen PHM, Blokx WAM, Kiemeney LALM, et al. Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up. Br J Dermatol 2005; 153: 1078-80.
23 - Kirkup ME (1999)
Kirkup ME, Berker DAR de. Clinical measurement of dimensions of basal cell carcinoma: effect of waiting for elective surgery. Br J Dermatol 1999; 141: 876-9.
24 - Kopf AW (1977)
Kopf AW, Bart RS, Schrager D, Lazar M, Popkin GL. Curetage-electrodesiccation treatment of basal cell carcinomas. Arch Dermatol 1977; 113: 439-43.
25 - Koplin L (1980)
Koplin L, Zarem HA. Recurrent basal cell carcinoma: a review concerning the incidence, behaviour and management of recurrent basal cell carcinoma, with emphasis on the incompletely excised lesion. Plast Reconstr Surg 1980; 65: 656-64.
26 - Kuflik EG (2004)
Kuflik EG. Cryosurgery for skin cancer: 30-year experience and cure rates. Derm Surg 2004; 30: 297-300.
27 - Landthaler M (1995)
Landthaler M, Hagspiel HJ, Braun-Falco O. Late irradiation damage to the skin caused by soft Xray radiation therapy of cutaneous tumors. Arch Dermatol 1995; 131: 182-6.
28 - Launis J (1993)
Launis J. Curettage for treatment of non-melanoma skin cancer [abstract]. Melanoma Research 1993; 3: 27.
29 - Lingren G (1997)
Lingren G, Larko O. Long term follow-up of cryosurgery of basal cell carcinoma of the eyelid. J Am Acad Dermatol 1997; 36: 742-6.
30 - Liu FF (1991)
Liu FF, Maki R, Warde P, Fitzpatrick P. A management approach to incompletely excised basal cell carcinomas of the skin. Int J Radiat Oncol Biol Phys 1991; 20: 423-8.
31 - Lo JS (1991)
Lo JS, Snow SN, Reitzner GT, Mohs FE, Larson PO, Hruza GJ. Metastatic basal cell carcinoma. Report of twelve cases with a review of the literature. J Am Acad Dermatol 1991; 24: 715-19.
32 - Marchac D (1982)
Marchac D, Papadopoulos O, Duport G. Curative and aesthetic results of surgical treatment of 138 basal cell carcinomas. J Dermatol Surg Oncol 1982; 8: 379-87.
33 - Marcil I (2000)
Marcil I. Stern RS. Risk of developing a subsequent non-melanoma skin cancer in patients with a history of non-melanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 2000; 136: 1524-30.
34 - Marks R (2001)
Marks R, Gebauer K, Shumack S, Amies M, Bryden J, Fox TL, et al. Imiquimod 5% cream in the treatment of superficieal basal cell carcinoma. Results of a multicenter 6-week dose-resonse trial. J Am Acad Dermatol 2001; 44: 807-13.
35 - McDaniel WE (1983)
McDaniel WE. Therapy for basal cell epitheliomas by curettage only. Further study. Arch Dermatol 1983; 119: 901-3.
36 - Mohs FE (1988)
Mohs FE, Larson P, Iriondo M. Micrographic surgery for the microscopically controlled excision of carcinoma of the external ear. Acad Dermatol 1988; 19: 729-37.
37 - Mohs FE (1986)
Mohs FE. Micrographic surgery for the microscopically controlled excision of eyelid cancers. Arch Ophthalmol 1986; 104: 901-9.
38 - Nagore E (2003)
Nagore E, Grau C, Molinero J, Fortea JM. Positive margins in basal cell carcinoma: relationship to clinical features and recurrence risk. A retrospective study of 248 patients. J Eur Acad Venereol 2003; 17: 167-70.
39 - Nordin P (1997)
Nordin P, Larko O, Stenquist B. Five-year results of curettage-cryosurgery of selected large primary basal cell carcinomas on the nose: an alternative treatment in a geographical area underserved by Mohs’ surgery. Br J Dermatol 1997; 136: 180-3.
40 - Reymann F (1979)
Reymann F. Treatment of basal cell carcinoma of the skin with 5-fluorouracil ointment. Dermatologica 1979; 158: 368-72.
41 - Rhodes LE (2007)
Rhodes LE, Rie M de, Leifdottir R, Yu RC, Bachmann I, et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate phototherapy vs surgery for nodular basal cell carcinoma. Arch Dermatol 2007; 143: 1131-6.Richmond JD, Davie RM. The significance of incomplete excision in patients with basal cell carcinoma. Br J Plast Surg 1987; 40: 63-7.
42 - Rowe DE (1989)
Rowe DE, Carroll RJ, Day CL. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15: 315-28 (a).
43 - Rowe DE (1989)
Rowe DE, Carroll RJ, Day CL. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989; 15: 424-3 (b).
44 - Rubin AI (2005)
Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med 2005; 353: 2262-9.
45 - Sarma DP (1984)
Sarma DP, Griffing CC, Weilbaecher TG. Observations on the inadequately excised basal cell carcinoma. J Surg Oncol 1984; 25: 79-80.
46 - Schulze HJ (2005)
Schulze HJ, Cribier B, Requena L, Reifenberger J, Ferrandiz C, Garcia Diez A, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehiclecontrolled phase III study in Europe. Br J Dermatol 2005; 152: 939-47.
47 - Shumack S (2002)
Shumack S, Robinson J, Kossard S, Golitz L, Greenway H, Schroeter A, et al. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Arch Dermatol 2002; 138: 1165-71.
48 - Silverman MK (1992)
Silverman MK, Kopf AW, Bart RS, Grin CM, Levenstein MS. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol 1992; 18: 471-6 (a).
49 - Silverman MK (1992)
Silverman MK, Kopf AW, Gladstein AH, Bart RS, Grin CM, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy. J Dermatol Surg Oncol 1992; 18: 549-54 (b).
50 - Silverman MK (1991)
Silverman MK, Kopf AW, Grin CM, Bart RS, Levenstein MJ. Recurrence rate of treated basal cell carcinoma. Part 2: curettage and electrodesiccation. J Dermatol Surg Oncol 1991; 17: 720-6.
51 - Smeets NW (2004)
Smeets NW, Kuijpers DI, Nelemans P, Ostertag JU, Verhaegh ME, Krekels GA, et al. Mohs’ micrographic surgery for treatment of basal cell carcinoma of the face – results of a retrospective study of the literature. Br J Dermatol 2004; 151: 141-7 (b).
52 - Smeets NWJ (2004)
Smeets NWJ, Krekels GAM, Ostertag JU, Essers BAB, Dirksen CD, Nieman FHM, et al. Surgical excision vs Mohs’ micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 2004; 364: 1766-72 (a).
53 - Sterry W (2002)
Sterry W, Ruzicka T, Herrera E, Takwale A, Bichel J, Andres K, et al. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing lowfrequency dosing with and without occlusion. Br J Dermatol 2002; 147: 1227-36.
54 - Telfer NR (1999)
Telfer NR, Colver GB, Bower PW. Guidelines for the management of basal cell carcinoma. British Association of Dermatologists. Br J Dermatol 1999; 141: 415-23.
55 - Thissen MRTM (2000)
Thissen MRTM, Nieman FHM, Ideler AHLB, Berretty PJM, Neumann HAM. Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatol Surg 2000; 26: 759-64.
56 - Wagner RF (1987)
Wagner RF. Multi focal recurrent basalcelcarcinoma following primary tumor treatment by electro dissecation and curretage. J Am Acad Dermatol 1987; 17: 1047-9.
57 - Wang I (2001)
Wang I, Bendsoe N, Klinterberg C, Enejder A, Andersson-Engels S, Svanberg S, et al. Photodynamic therapy versus cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001; 144: 832-40.
58 - Wennberg A-M (1999)
Wennberg A-M, Larkö O, Stenquist B. Five-year results of Mohs’ micrographic surgery for aggressive facial basal cell carcinoma in Sweden. Acta Derm Venereol 1999; 79: 370-2.
59 - Wolf DJ (1987)
Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Arch Dermatol 1987; 123: 340-4.
60 - Zacarian S (1983)
Zacarian S. Cryosurgery of cutaneous carcinomas. An 18-year study of 3022 patients with 4228 carcinomas. J Am Acad Dermatol 1983; 9: 947-56.